ORCHPHARMA

ORCHID PHARMA

Pharmaceuticals Small Cap BSE: 524372 NSE: ORCHPHARMA
₹279.00
-4 (-1.41%)
As on 01 July, 2022 | 08:03

Orchid Pharma Share Price

Orchid Pharma Performance

Day Range

  • Low 268.85
  • High 289

52 Week Range

  • Low 265
  • High 913.7
  • Open Price 276
  • Previous Close 283
  • Volume 3265

Orchid Pharma Share Returns

  • Over 1 Month -4.07%
  • Over 3 Month 4.6%
  • Over 6 Month -27.61%
  • Over 1 Year -68.9%

Orchid Pharma Key Statistics

P/E Ratio -222.5
PEG Ratio -5.9
Market Cap Cr 1138.8
Price to Book Ratio 149.3
EPS -1.3
Dividend 0
Relative Strength Index 43.33
Money Flow Index 27.56
MACD Signal -7.44
Average True Range 16.52

Orchid Pharma Investment Rating

  • Master Rating:
  • Orchid Pharma has an operating revenue of Rs. 559.56 Cr. on a trailing 12-month basis. An annual revenue growth of 22% is outstanding, Pre-tax margin of -10% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 32%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 50 which is a POOR score indicating inconsistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D+ which indicates heavy supply, Group Rank of 107 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Orchid Pharma Financials
  • Indicator
  • Mar 2022
  • Dec 2021
  • Sep 2021
  • Jun 2021
  • Mar 2021
  • Oper Rev
    Qtr Cr
  • 180.23
  • 159.30
  • 121.91
  • 95.54
  • 120.49
  • Operating Expenses
    Qtr Cr
  • 150.76
  • 143.40
  • 114.46
  • 91.09
  • 96.78
  • Operating Profit
    Qtr Cr
  • 29.48
  • 15.89
  • 7.44
  • 4.45
  • 23.72
  • Depreciation
    Qtr Cr
  • 26.63
  • 20.22
  • 20.06
  • 20.11
  • 20.32
  • Interest
    Qtr Cr
  • 4.46
  • 6.78
  • 9.89
  • 10.88
  • 11.89
  • Tax
    Qtr Cr
  • 0.00
  • 0.00
  • 0.00
  • 0.00
  • 0.00
  • Net Profit
    Qtr Cr
  • -1.78
  • -8.99
  • 31.99
  • -26.02
  • -27.23

Orchid Pharma Technicals

EMA & SMA

Current Price
284.15
1.15 (0.41%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 289.92
  • 50 Day
  • 303.32
  • 100 Day
  • 321.04
  • 200 Day
  • 359.95
  • 20 Day
  • 289.72
  • 50 Day
  • 310.29
  • 100 Day
  • 310.52
  • 200 Day
  • 360.02

Orchid Pharma Resistance and Support

PIVOT
₹285.82
Resistance
  • First Resistance
  • 289.64
  • Second Resistance
  • 296.27
  • Third Resistance
  • 300.09
Support
  • First Resistance
  • 279.19
  • Second Resistance
  • 275.37
  • Third Resistance
  • 268.74
  • RSI
  • 43.33
  • MFI
  • 27.56
  • MACD Single Line
  • -7.44
  • MACD
  • -6.49

Orchid Pharma Delivery and Volume

  • Period
  • NSE + BSE
    Volume Avg
  • NSE + BSE
    Delivery Volume Avg
  • NSE + BSE
    Delivery Volume %
  • Day
  • 4,229
  • 422,900
  • 100
  • Week
  • 2,770
  • 277,000
  • 100
  • 1 Month
  • 2,717
  • 271,686
  • 100
  • 6 Month
  • 24,663
  • 1,850,466
  • 75.03

Orchid Pharma Result Highlights

Orchid Pharma Synopsis

NSE-Medical-Diversified

Orchid Pharma is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 556.97 Cr. and Equity Capital is Rs. 40.82 Cr. for the Year ended 31/03/2022. Orchid Pharma Ltd. is a Public Limited Listed company incorporated on 01/07/1992 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24222TN1992PLC022994 and registration number is 022994.
  • Market Cap
  • 1,138.77
  • Sales
  • 556.97
  • Shares in Float
  • 0.41
  • No of funds
  • 19
  • Yield
  • Book Value
  • 1.68
  • U/D Vol ratio
  • 0.5
  • LTDebt / Equity
  • 31
  • Alpha
  • -0.4
  • Beta
  • 0.89

Orchid Pharma

  • Owner Name
  • Jun -21
  • Promoters
  • 90%
  • Mutual Funds
  • 2.45%
  • Insurance Companies
  • 0.03%
  • Foreign Portfolio Investors
  • 1.79%
  • Financial Institutions/ Banks
  • 0.97%
  • Individual Investors
  • 2.34%
  • Others
  • 2.42%

Orchid Pharma Management

  • Name
  • Designation
  • Mr. Ram Gopal Agarwal
  • Chairman & Non-Exe.Director
  • Mr. Manish Dhanuka
  • Managing Director
  • Mr. Mridul Dhanuka
  • Whole Time Director
  • Mr. Arun Kumar Dhanuka
  • Non Executive Director
  • Mrs. Tanu Singla
  • Independent Director
  • Dr. Dharam Vir
  • Independent Director
  • Mr. Manoj Kumar Goyal
  • Independent Director
  • Mr. Mudit Tandon
  • Independent Director

Orchid Pharma Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Orchid Pharma Corporate Action

  • Date
  • Purpose
  • Remarks
  • 2022-05-12
  • Audited Results
  • 2022-02-12
  • Quarterly Results
  • 2021-11-14
  • Quarterly Results
  • 2021-08-13
  • Quarterly Results
  • 2021-07-15
  • Others
  • inter-alia, to consider and approve: Fund raising by way of issuance of equity shares through preferential allotment/private placement in single/multiple tranches.

Orchid Pharma MF Shareholding

  • Name
  • Amount(cr)
  • Nippon India Pharma Fund - Growth
  • 4515.92

Orchid Pharma Similar Stocks

Company Name
Marksans Pharma Ltd
  • 52 week
  • 93.50
  • Market price
  • 43.40 (2.48%)
  • Volume
  • 316270
  • 52 week
  • 124.70
  • Market price
  • 57.95 (-2.28%)
  • Volume
  • 1118
Company Name
Gufic BioSciences Ltd
  • 52 week
  • 289.55
  • Market price
  • 222.25 (-2.78%)
  • Volume
  • 4337
Company Name
Ortin Laboratories Ltd
  • 52 week
  • 39.75
  • Market price
  • 21.50 (1.18%)
  • Volume
  • 2866

Orchid Pharma News

Orchid Pharma Ltd - 524372 - Closure of Trading Window

Notice of closure of trading window

Orchid Pharma Ltd - 524372 - Intimation About Book Closure-29Th AGM Of The Company

Intimation about Book Closure-29th AGM of the Company

Orchid Pharma Ltd - 524372 - Reg. 34 (1) Annual Report.

Orchid Pharma Limited - Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) regulations,2015-Annual report-2021-2022 and Notice of 29th AGM

Orchid Pharma FAQs

What is Share Price of Orchid Pharma ?

Orchid Pharma share price is ₹279 As on 01 July, 2022 | 07:49

What is the Market Cap of Orchid Pharma ?

The Market Cap of Orchid Pharma is ₹1138.8 As on 01 July, 2022 | 07:49

What is the P/E ratio of Orchid Pharma ?

The P/E ratio of Orchid Pharma is -583.6 As on 01 July, 2022 | 07:49

What is the PB ratio of Orchid Pharma ?

The PB ratio of Orchid Pharma is 1.8 As on 01 July, 2022 | 07:49